Children with multi-drug resistant tuberculosis (MDR-TB) undergo months of life-saving treatment including many doses of foul-tasting medications, which caregivers often struggle to prepare and administer accurately. New findings from the Global Alliance for TB Drug Development (TB Alliance) and Stellenbosch University, in South Africa now provide detailed blueprints for pharmacists to quickly and safely prepare more palatable, more accurately dosed syrup suspensions for key drugs against MDR- TB. The researchers hope their work will significantly improve treatment outcomes of children with MDR-TB. Read more here.
top of page
Recent Posts
See AllThe results of the TB-CHAMP trial were recently published. They showed that prophylactic levofloxacin can significantly reduce the risk...
190
This month, the Indian Patent Office denied the last of the three Janssen patent extension applications for bedaquiline. While TB...
100
The Institute of Tropical Medicine has announced two initiatives to honor the legacy of Armand Van Deun: a new meeting room in his name...
560
bottom of page
Commenti